Measuring and reducing unnecessary medication prescriptions in older adults
The Development, Validation, and Application of a Claims-based Metric of Low Value Prescribing in Older Adults
This study is looking at how to make sure older adults, 65 and up, are only getting the medications they really need, by finding ways to cut down on unnecessary prescriptions and making sure everyone's opinions are heard, so that their care is safer and better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10684898 on NIH RePORTER |
What this research studies
This research focuses on identifying and reducing low-value prescribing practices among adults aged 65 and older. It aims to develop a new metric that evaluates medications based on their benefits versus costs and harms, incorporating insights from patients, healthcare providers, and payers. By analyzing claims data, the study seeks to create a systematic approach to measure and address unnecessary prescriptions, ultimately improving medication safety and reducing healthcare waste. The goal is to enhance the quality of care for older adults while ensuring their perspectives are considered.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 65 and above who are currently taking multiple medications.
Not a fit: Patients under the age of 65 or those not on multiple medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer medication practices and reduced healthcare costs for older adults.
How similar studies have performed: Previous research has shown success in reducing low-value healthcare services, but this specific approach to medication prescribing is novel.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Radomski, Thomas — University of Pittsburgh at Pittsburgh
- Study coordinator: Radomski, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.